Venrock Healthcare Capital Partners II, L.P. - Jun 28, 2022 Form 4 Insider Report for Tricida, Inc. (TCDA)

Role: 10%+ Owner
Signature: /s/ David L. Stepp, Authorized Signatory
Stock symbol: TCDA
Transactions as of: Jun 28, 2022
Transactions value $: $613,510
Form type: 4
Date filed: 6/30/2022, 04:57 PM
Previous filing: Jun 24, 2022
Next filing: Jul 6, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TCDA	Common Stock	Purchase	$334K	+34.4K	+0.49%	$9.71^*	7.1M	Jun 28, 2022	By Funds	F1, F2, F3
transaction	TCDA	Common Stock	Purchase	$164K	+16.5K	+0.23%	$9.93^*	7.12M	Jun 29, 2022	By Funds	F3, F4, F5
transaction	TCDA	Common Stock	Purchase	$116K	+12K	+0.17%	$9.66^*	7.13M	Jun 30, 2022	By Funds	F3, F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of (i) 3,567 shares purchased by Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), (ii) 1,442 shares purchased by VHCP Co- Investment Holdings II, LLC ("VHCP Co-2"), (iii) 7,715 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (iv) 769 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (v) 20,873 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG").
F2	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.60 to $10.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F3	VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein.
F4	Consists of (i) 1,717 shares purchased by VHCP II, (ii) 695 shares purchased by VHCP Co-2, (iii) 3,715 shares purchased by VHCP III, (iv) 371 shares purchased by VHCP Co-3 and (v) 10,048 shares purchased by VHCP EG.
F5	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.87 to $10.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F6	Consists of (i) 1,241 shares purchased by VHCP II, (ii) 502 shares purchased by VHCP Co-2, (iii) 2,685 shares purchased by VHCP III, (iv) 268 shares purchased by VHCP Co-3 and (v) 7,262 shares purchased by VHCP EG.
F7	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.46 to $9.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.